Pharming Group N.V.
PHAR | NASDAQ
$12.66
+$0.43 (+3.52%)
Nov 2, 2026, 11:22 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 189.56M | 158.28M | 53.1M | 146.02M | 112.75M | 94.82M | 60.09M | 54.94M | 60.66M | 44.01M | 48.09M | 61.74M | 51.7M | 176.29M | 170.35M | 207.34M | 192.57M | 181.32M | 171.45M | 217.59M | 212.76M | 187.77M | 207.51M |
Short-Term Investments | n/a | n/a | 117.8M | 33.79M | 28.79M | 33.92M | 47.18M | 112.95M | 111.1M | 105.65M | 139.08M | 151.68M | 135.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 9.95M | 8.58M | 9.01M | 9.87M | 5.68M | 8.72M | 5.92M | 4.23M | 8.71M | 6.87M | 7.12M | 10.4M | 8.74M | 8.84M | 9M | 9.73M | 11M | 11.1M | 6.69M | 9.81M | 11.62M | 7.24M | 7.58M |
Other Long-Term Assets | 91K | 1.32M | 92K | 93.98K | 25.21M | 95K | 1.67M | 1.6M | 93K | 37.93M | 34.54M | 1.62M | 26.64M | 26.41M | 28.39M | 1.33M | 22.04M | 18.67M | 19.19M | 1.14M | 393.12K | 24.35M | n/a |
Receivables | 74.83M | 56.98M | 60.03M | 54.69M | 37.14M | 53.33M | 47.49M | 50.17M | 48.2M | 47.72M | 35.86M | 42.62M | 38.33M | 30.39M | 30.36M | 25.33M | 29.42M | 31.38M | 28.42M | 31.28M | 38.08M | 37.45M | 32.93M |
Inventory | 57.99M | 65.43M | 64.58M | 64.88M | 57.19M | 63.72M | 59.35M | 55.72M | 62.23M | 55.25M | 51.79M | 56.76M | 50.55M | 48.61M | 44.37M | 42.33M | 34.19M | 32.39M | 26.76M | 30.96M | 29.13M | 24.24M | 21.76M |
Other Current Assets | n/a | n/a | n/a | 1K | 587.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 200.53K | n/a | 200.98K | 213K | 1.03M | 199.49K | 200.67K | 257.35K | 1.14M | 984.52K | n/a |
Total Current Assets | 322.38M | 280.69M | 295.51M | 299.38M | 236.46M | 245.78M | 214.11M | 278.44M | 282.19M | 252.63M | 274.81M | 316.34M | 275.95M | 255.28M | 245.28M | 277.5M | 257.21M | 245.29M | 226.83M | 282.8M | 281.11M | 250.44M | 262.19M |
Property-Plant & Equipment | 19.5M | 20.48M | 23.1M | 23.96M | 21.29M | 24.57M | 24.23M | 24.13M | 30.67M | 28.68M | 29.53M | 33.47M | 35.45M | 36.06M | 37.59M | 39.15M | 28.35M | 28.59M | 28.83M | 37.6M | 43.98M | 37.52M | 21.91M |
Goodwill & Intangibles | 125.67M | 128.08M | 130.99M | 135.5M | 114.93M | 135.9M | 138.86M | 61.04M | 67.1M | 62.14M | 63.29M | 71.27M | 66.07M | 67.28M | 69.7M | 75.12M | 71.56M | 72.32M | 73.51M | 95.04M | 103.3M | 91.13M | 89.91M |
Total Long-Term Assets | 174.26M | 187.3M | 193.85M | 200.43M | 167.11M | 200.48M | 189.08M | 121.55M | 143.32M | 135.63M | 134.48M | 146.51M | 136.9M | 138.59M | 144.68M | 148.3M | 132.95M | 130.69M | 128.22M | 167.64M | 184.22M | 160.24M | 146.95M |
Total Assets | 496.64M | 467.98M | 489.37M | 499.81M | 403.57M | 446.26M | 403.18M | 399.99M | 425.51M | 388.27M | 409.29M | 462.85M | 412.85M | 393.87M | 389.96M | 425.8M | 390.16M | 375.98M | 355.05M | 450.44M | 465.33M | 410.69M | 409.14M |
Account Payables | 90.07M | 82.32M | 103.53M | 105.87M | 66.63M | 78.38M | 68.75M | 10.1M | 72.64M | 68.11M | 63.49M | 16.02M | 59.16M | 54.34M | 49.09M | 8.75M | 43.62M | 43.02M | 36.9M | 8.62M | 48.92M | 43M | 43.67M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 9.07M | 5.47M | 8.15M | 5.34M | 4.44M | 5.11M | 4.56M | 4.25M | 3.32M | 2.94M | 125M | 1.82M | 1.65M | 1.65M | 1.66M | 1.77M | 1.66M | 1.65M | 1.67M | 2.13M | 2.23M | 1.97M | 4.97M |
Other Current Liabilities | 816K | 1.88M | 675K | 1.22M | -851 | n/a | n/a | 40.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 61.93K | 71.17K | 25.18M |
Total Current Liabilities | 99.95M | 93.25M | 112.35M | 115.79M | 74.89M | 87.94M | 77.54M | 73.8M | 79.84M | 74.62M | 192.09M | 77.97M | 64.38M | 59.52M | 54.39M | 59.7M | 47.65M | 46.96M | 40.81M | 53.02M | 54.22M | 47.68M | 73.81M |
Long-Term Debt | 94.34M | 92.4M | 93.39M | 92.72M | 79.33M | 91.27M | 83.85M | 78.15M | 92.1M | 81.52M | n/a | 136.6M | 122.71M | 122.97M | 123.14M | 131.62M | 122.47M | 122.4M | 122.54M | 157.59M | 163.6M | 145.03M | 141.12M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | -851 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 145.93K | 145.09K | 146.43K | 187.06K | 448.31K | 188.6K | 188.93K |
Total Long-Term Liabilities | 105.45M | 104.25M | 108.06M | 107.07M | 103.26M | 118.77M | 110.36M | 105.12M | 119.88M | 107.4M | 26.35M | 166.11M | 149.89M | 150.73M | 151.79M | 161.46M | 138.15M | 138.43M | 138.86M | 178.7M | 186.47M | 165.49M | 149.05M |
Total Liabilities | 205.4M | 197.49M | 220.41M | 222.79M | 178.15M | 206.71M | 187.89M | 178.92M | 199.72M | 182.02M | 218.44M | 244.07M | 214.27M | 210.25M | 206.19M | 221.16M | 185.8M | 185.39M | 179.67M | 231.73M | 240.7M | 213.17M | 222.85M |
Total Debt | 114.51M | 113.3M | 116.21M | 115.78M | 111.52M | 128.33M | 119.14M | 112.31M | 127.08M | 113.91M | 154.95M | 171.55M | 155.11M | 155.91M | 157.09M | 166.69M | 142.04M | 142.22M | 142.62M | 183.39M | 191.27M | 169.91M | 153.82M |
Book Value | 291.24M | 270.49M | 268.96M | 277.02M | 225.42M | 239.55M | 215.29M | 221.06M | 225.79M | 206.24M | 190.85M | 218.78M | 198.58M | 183.62M | 183.77M | 204.64M | 204.36M | 190.59M | 175.38M | 218.71M | 224.63M | 197.51M | 186.29M |
Book Value Per Share | 3.90 | 3.86 | 3.83 | 3.66 | 3.37 | 3.58 | 3.22 | 3.25 | 3.49 | 2.43 | 2.28 | 2.61 | 2.42 | 2.79 | 2.24 | 2.49 | 2.36 | 2.20 | 2.03 | 2.50 | 3.52 | 2.47 | 2.27 |
Common Stock | 8.09M | 8.08M | 8.06M | 8.01M | 6.77M | 7.82M | 7.81M | 7.77M | 7.75M | 7.23M | 7.12M | 7.67M | 7.24M | 6.91M | 6.93M | 7.51M | 7.64M | 7.13M | 6.75M | 8.42M | 8.43M | 7.23M | 7.19M |
Retained Earnings | -255.28M | -278.25M | -281.46M | -272.9M | -213.82M | -286.03M | -292.8M | -275.49M | -278.37M | -255.46M | -260.77M | -265.26M | -258.88M | -248.83M | -250.2M | -256.43M | -272.14M | -254.05M | -245.33M | -309.69M | -321.55M | -261.47M | -281.22M |
Comprehensive Income | 17.52M | 20.34M | 23.75M | n/a | n/a | 25.91M | 8.69M | -209K | 9.33M | n/a | n/a | -2.06M | n/a | n/a | n/a | -8.74M | n/a | n/a | n/a | 3.85M | 11.45M | n/a | 11.35M |
Shareholders Equity | 291.24M | 270.49M | 268.96M | 277.02M | 225.42M | 239.55M | 214M | 221.06M | 225.79M | 206.24M | 190.85M | 218.78M | 198.58M | 183.62M | 183.77M | 204.64M | 204.36M | 190.59M | 175.38M | 218.71M | 224.63M | 197.51M | 186.29M |
Total Investments | 9.95M | 8.58M | 126.8M | 43.66M | 34.47M | 42.64M | 53.1M | 117.18M | 119.82M | 112.53M | 146.2M | 162.08M | 143.92M | 8.84M | 9M | 9.73M | 11M | 11.1M | 6.69M | 9.81M | 11.62M | 7.24M | 7.58M |
Add to Watchlist
Select watchlists to add or remove PHAR